$108.85
0[0.00%]
At close: Apr 24
$108.85
0[0.00%]
PreMarket: 7:54PM EDT
Moderna reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Moderna using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | AM | MRNA | Q1 | $0.19 | -$3.21 | — | — | $1.86B | $313.36M | — | — | Get Alert |
02/22/2024 | AM | MRNA | Q4 | $3.61 | -$0.97 | $0.55 | 156.70% | $5.08B | $2.49B | $2.81B | 12.89% | Get Alert |
11/02/2023 | AM | MRNA | Q3 | $2.53 | -$1.93 | -$9.53 | -393.78% | $3.36B | $1.40B | $1.83B | 30.79% | Get Alert |
08/03/2023 | AM | MRNA | Q2 | $5.24 | -$3.84 | -$3.62 | 5.73% | $4.75B | $290.74M | $344.00M | 18.32% | Get Alert |
05/04/2023 | AM | MRNA | Q1 | $8.58 | -$1.77 | $0.19 | 110.73% | $6.07B | $1.18B | $1.86B | 57.80% | Get Alert |
02/23/2023 | AM | MRNA | Q4 | $11.29 | $4.68 | $3.61 | -22.86% | $7.21B | $5.02B | $5.08B | 1.27% | Get Alert |
11/03/2022 | AM | MRNA | Q3 | $7.70 | $3.29 | $2.53 | -23.10% | $4.97B | $3.53B | $3.36B | -4.70% | Get Alert |
08/03/2022 | AM | MRNA | Q2 | $6.46 | $4.59 | $5.24 | 14.16% | $4.35B | $4.07B | $4.75B | 16.68% | Get Alert |
05/04/2022 | AM | MRNA | Q1 | $2.84 | $5.21 | $8.58 | 64.68% | $1.94B | $4.43B | $6.07B | 36.93% | Get Alert |
02/24/2022 | AM | MRNA | Q4 | -$0.69 | $9.90 | $11.29 | 14.04% | $570.75M | $6.79B | $7.21B | 6.20% | Get Alert |
11/04/2021 | AM | MRNA | Q3 | -$0.59 | $9.09 | $7.70 | -15.29% | $157.91M | $6.23B | $4.97B | -20.24% | Get Alert |
08/05/2021 | AM | MRNA | Q2 | -$0.31 | $6.04 | $6.46 | 6.95% | $66.35M | $4.28B | $4.35B | 1.73% | Get Alert |
05/06/2021 | AM | MRNA | Q1 | -$0.35 | $2.39 | $2.84 | 18.83% | $8.39M | $2.04B | $1.94B | -5.05% | Get Alert |
02/25/2021 | AM | MRNA | Q4 | -$0.37 | — | -$0.69 | — | $14.05M | — | $570.75M | — | Get Alert |
10/29/2020 | AM | MRNA | Q3 | -$0.37 | -$0.43 | -$0.59 | -37.21% | $17.05M | $77.51M | $157.91M | 103.73% | Get Alert |
08/05/2020 | AM | MRNA | Q2 | -$0.41 | -$0.35 | -$0.31 | 11.43% | $13.08M | $27.43M | $66.35M | 141.89% | Get Alert |
05/07/2020 | AM | MRNA | Q1 | -$0.40 | -$0.35 | -$0.35 | 0.00% | $16.02M | $17.09M | $8.39M | -50.91% | Get Alert |
02/26/2020 | AM | MRNA | Q4 | -$0.43 | -$0.42 | -$0.37 | 11.90% | $35.42M | $17.37M | $14.05M | -19.08% | Get Alert |
11/06/2019 | AM | MRNA | Q3 | — | -$0.43 | -$0.37 | 13.95% | — | $18.36M | $17.05M | -7.16% | Get Alert |
Moderna (MRNA) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $0.55, which beat the estimate of $-0.97.
The Actual Revenue was $2.8B, which beat the estimate of $2.5B.
Browse earnings estimates, EPS, and revenue on all stocks.